LEXARIA BIOSCIENCE CORP.: 10-Q filed 2014-11-14

Name: LEXARIA BIOSCIENCE CORP.: 10-Q filed 2014-11-14
Creator: LEXARIA BIOSCIENCE CORP.

What LEXARIA BIOSCIENCE CORP. reported in its quarterly report filed 2014-11-14 (fiscal Q3 2014): 23 published measures, 66 facts as tagged in accession 0001062993-14-006722.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-11-14
Fiscal period: fiscal Q3 2014
Accession: 0001062993-14-006722 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LEXARIA BIOSCIENCE CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-07-31	4,566,208	USD
At 2013-10-31	3,573,352	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-07-31	1,016,663	USD
At 2013-10-31	1,474,448	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2014-07-31	3,549,545	USD
At 2013-10-31	2,098,904	USD
At 2012-10-31	2,421,176	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-07-31	578,475	USD
At 2013-10-31	65,542	USD
At 2013-07-31	27,529	USD
At 2012-10-31	180,514	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-11-01 to 2014-07-31	-411,679	USD	273
2012-11-01 to 2013-07-31	246,726	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-11-01 to 2014-07-31	1,032,596	USD	273
2012-11-01 to 2013-07-31	-335,330	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2013-11-01 to 2014-07-31	-107,984	USD	273
2012-11-01 to 2013-07-31	-64,381	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-07-31	-6,229,268	USD
At 2013-10-31	-5,057,677	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2014-05-01 to 2014-07-31	25,433	USD	92
2013-11-01 to 2014-07-31	91,915	USD	273
2013-05-01 to 2013-07-31	21,279	USD	92
2012-11-01 to 2013-07-31	21,279	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-05-01 to 2014-07-31	-567,954	USD	92
2013-11-01 to 2014-07-31	-1,163,178	USD	273
2013-05-01 to 2013-07-31	-57,669	USD	92
2012-11-01 to 2013-07-31	-217,283	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-07-31	1,200,664	USD
At 2013-10-31	146,266	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-05-01 to 2014-07-31	39,020	USD	92
2013-11-01 to 2014-07-31	147,166	USD	273
2013-05-01 to 2013-07-31	41,692	USD	92
2012-11-01 to 2013-07-31	208,326	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-07-31	957,418	USD
At 2013-10-31	1,415,203	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2014-07-31	98,683	USD
At 2013-10-31	79,217	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-05-01 to 2014-07-31	621,717	USD	92
2013-11-01 to 2014-07-31	1,307,865	USD	273
2013-05-01 to 2013-07-31	133,820	USD	92
2012-11-01 to 2013-07-31	510,047	USD	273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2014-05-01 to 2014-07-31	53,763	USD	92
2013-11-01 to 2014-07-31	144,687	USD	273
2013-05-01 to 2013-07-31	76,151	USD	92
2012-11-01 to 2013-07-31	292,764	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2014-05-01 to 2014-07-31	82,100	USD	92
2013-11-01 to 2014-07-31	319,111	USD	273
2013-05-01 to 2013-07-31	175,330	USD	92
2012-11-01 to 2013-07-31	563,596	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-07-31	32,824,664	shares
At 2013-10-31	16,431,452	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-07-31	9,745,989	USD
At 2013-10-31	7,140,150	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2014-07-31	523,506	USD
At 2013-10-31	1,507	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-05-01 to 2014-07-31	-576,367	USD	92
2013-11-01 to 2014-07-31	-1,171,591	USD	273
2012-11-01 to 2013-10-31	-343,551	USD	365
2013-05-01 to 2013-07-31	-57,669	USD	92
2012-11-01 to 2013-07-31	-217,283	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-05-01 to 2014-07-31	4,887	USD	92
2013-11-01 to 2014-07-31	10,972	USD	273
2013-05-01 to 2013-07-31	410	USD	92
2012-11-01 to 2013-07-31	6,461	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-11-01 to 2014-07-31	19,466	USD	273
2012-11-01 to 2013-07-31	-139,117	USD	273

Inspect the source

Entity: LEXARIA BIOSCIENCE CORP. / CIK 0001348362
Captured: 2026-09-20T07:55:03.045Z
SEC response SHA-256: c8696dbfbdb8ee1a7522ea5b45a8c2d45cb12720b3d84857c1cda6bba2861389

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001348362.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))